alpha-Thalassemia
|
0.300 |
Biomarker
|
disease |
BEFREE |
The ATRX protein belongs to the SWI/SNF family of chromatin remodeling proteins, which are frequently associated with α-thalassemia syndrome.
|
29725455 |
2018 |
alpha-Thalassemia
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
ATRX germline variations are responsible for the rare genetic disorder X-linked alpha-thalassemia mental retardation (ATR-X) syndrome characterized by severe developmental delay and alpha-thalassemia but no obvious increased risk of cancer.
|
29706636 |
2018 |
alpha-Thalassemia
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Alpha-thalassemia mental retardation syndrome (ATR-X syndrome) is the most notable manifestation of ATRX dysfunction.
|
26860117 |
2017 |
alpha-Thalassemia
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Novel ATRX gene damaging missense mutation c.6740A>C segregates with profound to severe intellectual deficiency without alpha thalassaemia.
|
26997013 |
2016 |
alpha-Thalassemia
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
In parallel, alpha thalassaemia/mental retardation syndrome X linked (ATRX) gene mutations were also sought, a novel mutation being detected in 1/21 (4,7%) cases.
|
25925003 |
2015 |
alpha-Thalassemia
|
0.300 |
Biomarker
|
disease |
BEFREE |
Here, we identify the SWI/SNF helicase ATRX (α-thalassemia/MR, X-linked) as a novel macroH2A-interacting protein.
|
22391447 |
2012 |
alpha-Thalassemia
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
ATRX is a member of the Snf2 family of chromatin-remodelling proteins and is mutated in an X-linked mental retardation syndrome associated with alpha-thalassaemia (ATR-X syndrome).
|
21505078 |
2011 |
alpha-Thalassemia
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the ATRX protein are associated with the alpha-thalassemia and mental retardation X-linked syndrome (ATR-X).
|
21421568 |
2011 |
alpha-Thalassemia
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the ATRX gene are associated with X-linked mental retardation (XLMR) often accompanied by alpha thalassemia (ATRX syndrome).
|
20110566 |
2010 |
alpha-Thalassemia
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Acquired mutations in ATRX are observed in the preleukemic condition alpha thalassemia myelodysplastic syndrome (ATMDS).
|
18409179 |
2008 |
alpha-Thalassemia
|
0.300 |
AlteredExpression
|
disease |
LHGDN |
De novo and acquired forms of alpha thalassemia.
|
16537041 |
2006 |
alpha-Thalassemia
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
A novel mutation in the last exon of ATRX in a patient with alpha-thalassemia myelodysplastic syndrome.
|
16480427 |
2006 |
alpha-Thalassemia
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
In addition, it is unclear whether patients with MDS-associated acquired alpha thalassaemia (ATMDS), a special subgroup with a very high incidence of point mutations in the ATRX gene, have an especially high incidence of RUNX1 mutations.
|
15613106 |
2005 |
alpha-Thalassemia
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Acquired HbH has recently been associated with mutations in an X-linked gene, ATRX, previously linked to inherited ATR-X syndrome (alpha thalassemia-retardation-X linked).
|
16266892 |
2005 |
alpha-Thalassemia
|
0.300 |
GeneticVariation
|
disease |
LHGDN |
Acquired somatic ATRX mutations in myelodysplastic syndrome associated with alpha thalassemia (ATMDS) convey a more severe hematologic phenotype than germline ATRX mutations.
|
14592816 |
2004 |
alpha-Thalassemia
|
0.300 |
GeneticVariation
|
disease |
LHGDN |
Identification of acquired somatic mutations in the gene encoding chromatin-remodeling factor ATRX in the alpha-thalassemia myelodysplasia syndrome (ATMDS).
|
12858175 |
2003 |
alpha-Thalassemia
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Using this approach, we have shown that in individuals with myelodysplasia associated with alpha-thalassemia (ATMDS), somatic mutations of the gene encoding the chromatin remodeling factor ATRX cause an unexpectedly severe hematological phenotype compared with the wide spectrum of inherited mutations affecting this gene.
|
12858175 |
2003 |
alpha-Thalassemia
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the ATRX gene on the human X chromosome cause X-linked alpha-thalassemia and mental retardation.
|
11069290 |
2000 |
alpha-Thalassemia
|
0.300 |
Biomarker
|
disease |
BEFREE |
Since the identification of the ATRX gene (synonyms XNP, XH2) in 1995, it has been shown to be the disease gene for numerous forms of syndromal X-linked mental retardation [X-linked alpha thalassemia/mental retardation (ATR-X) syndrome, Carpenter syndrome, Juberg-Marsidi syndrome, Smith-Fineman-Myers syndrome, X-linked mental retardation with spastic paraplegia].
|
11449489 |
2000 |
alpha-Thalassemia
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
A point mutation in the XNP gene, associated with an ATR-X phenotype without alpha-thalassemia.
|
9043863 |
1996 |
alpha-Thalassemia
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
It was shown recently that mutations of the ATRX gene give rise to a severe, X-linked form of syndromal mental retardation associated with alpha thalassaemia (ATR-X syndrome).
|
8968741 |
1996 |
alpha-Thalassemia
|
0.300 |
Biomarker
|
disease |
MGD |
|
|
|